Belvedere Trading LLC Ambrx Biopharma Inc. Put Options Transaction History

Belvedere Trading LLC

  • $74.4 Billion
  • Q3 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2023

Oct 27, 2023
SELL
$9.3 - $16.6 $115,320 - $205,840
-12,400 Reduced 69.27%
5,500 $63,000
Q2 2023

Aug 08, 2023
BUY
$7.66 - $16.46 $136,348 - $292,988
17,800 Added 17800.0%
17,900 $294,000
Q1 2023

May 15, 2023
BUY
$1.46 - $12.54 $146 - $1,254
100 New
100 $0

Others Institutions Holding AMAM

# of Institutions
2
Shares Held
31.2K
Call Options Held
0
Put Options Held
0
View Full List

About Ambrx Biopharma Inc.

AMAM Quotes by TradingView
  • Ticker AMAM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,618,400
  • Market Cap $1.08B
  • Description
  • Ambrx Biopharma Inc., a clinical-stage biologics company, discovers and develops engineered precision biologics using its proprietary expanded genetic code technology platform. Its lead product candidate is ARX788, an anti-HER2 antibody-drug conjugate (ADC), which is investigated in various clinical trials for the treatment of breast cancer, gas...
More about AMAM
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email